Trichophyton Rubrum Infection: How a Lab-Grown Skin Model Is Changing Antifungal Research
If you’ve ever struggled with the itch of athlete’s foot or the red, circular rash of ringworm, you’ve encountered Trichophyton rubrum—the most common fungus behind human skin and nail infections worldwide. For decades, studying how this microbe invades skin and testing treatments has been tricky: animal models don’t match human biology, and flat cell cultures miss the 3D structure of real skin. But a 2016 study offers a breakthrough: a more realistic lab model of Trichophyton rubrum infection using Episkin®—a reconstructed human epidermis that mimics our skin’s layers and function.
The Problem with Old Research Tools
Before this study, scientists relied on two flawed methods to study fungal infections:
- Animal models: Mice and other animals have different skin biology, so results often don’t apply to humans.
- 2D cell cultures: These flat, single-layer cells fail to capture how fungi like Trichophyton rubrum penetrate skin’s multiple layers.
This gap made it hard to understand how infections start or how drugs work—until Episkin® changed the game.
Episkin®: Lab-Grown Skin That Acts Like Yours
Episkin® is a 3D reconstructed human epidermis: real human skin cells grown in a lab to form the same layers (like the outermost barrier, the stratum corneum) as natural skin. It’s a trusted tool in dermatology research because it behaves like the skin on your body—making it ideal for studying infections.
The Study: Testing Trichophyton Rubrum on Lab-Grown Skin
Led by Liang PP and colleagues (published in the Chinese Medical Journal in 2016), the team used Episkin® to create a Trichophyton rubrum infection model. Here’s what they found:
- Fungal Invasion: The fungus stuck to Episkin®’s surface and penetrated deeper layers—just like it does in real human skin.
- Inflammation: The model showed signs of immune response (via markers like IL-8, a protein linked to redness and itch)—matching what people experience with ringworm or athlete’s foot.
- Drug Testing Validity: The model accurately reflected how antifungal drugs work, proving it could help screen new treatments.
This wasn’t just a lab win—it was a milestone for translating research to real patients.
Why This Matters for You
For scientists, Episkin® provides a human-relevant way to study Trichophyton rubrum without relying on animals or unrealistic cell cultures. For people with fungal infections, this means faster development of targeted, effective treatments—no more guesswork with over-the-counter creams that might not work.
A Note on Transparency: The Funding Correction
In a later corrigendum, the authors clarified the study’s funding: it was supported by the Natural Science Foundation of Guangdong Province (grant number 2015A030313137). This small correction is big for trust—ensuring readers know the research was independently funded and results are unbiased.
The Future of Antifungal Research
Models like Episkin® are paving the way for smarter, more patient-centered science. As researchers refine this tool, we could see faster progress against Trichophyton rubrum and other stubborn fungi—meaning fewer itchy rashes and more solutions for the 1 in 5 people who deal with fungal skin infections.
Liang PP, Huang XZ, Yi JL, Chen ZR, Ma H, Ye CX, et al. A Trichophyton Rubrum infection model based on the reconstructed human epidermis – Episkin®. Chinese Medical Journal 2016;129:54–58. doi: 10.4103/0366-6999.172573
doi.org/10.1097/CM9.0000000000000452
Was this helpful?
0 / 0